Subscribe

News
Media
Conferences
DI Executive
Resources
Subscribe

Opinion|Videos|September 11, 2024

The Role of PSMA PET in Early Detection and Prostate Cancer Staging

Author(s)Jaideep S. Sohi, MD, Jeremie Calais, MD

Experts in radiology imaging evaluate the impact and efficacy of PSMA PET in improving early detection methods and refining prostate cancer staging processes.

Episodes in this series

2 KOLs are featured in this series.

EP. 1 PSMA PET vs. Gallium-Based PET: Navigating NCCN Guidelines in Prostate Cancer Imaging

2 KOLs are featured in this series.

EP. 2 Insights into the Benefit of PSMA PET Imaging Alongside Other Conventional Imaging Modalities in Prostate Cancer Care

2 KOLs are featured in this series.

EP. 3 The Role of PSMA PET in Early Detection and Prostate Cancer Staging

2 KOLs are featured in this series.

EP. 4 Understanding Oligometastatic Disease in Prostate Cancer: Insights from PSMA PET Imaging

2 KOLs are featured in this series.

EP. 5 Navigating Oligometastatic Disease: Understanding Lesion Numbers, Metastasis, and Disease Cutoffs in Clinical Practice

2 KOLs are featured in this series.

EP. 6 Evaluating Imaging Agents in Oligometastatic Prostate Cancer: A Comparative Analysis of Gallium-Based and Non-Gallium-Based Options

2 KOLs are featured in this series.

EP. 7 Optimal Timing and Frequency of Imagining Agents Used in the Detection and Characterization of Oligometastatic Prostate Cancer

2 KOLs are featured in this series.

EP. 8 Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams

2 KOLs are featured in this series.

EP. 9 Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability

2 KOLs are featured in this series.

EP. 10 Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related Content

Cancer Imaging and the Future of Prostate Cancer Care

December 23rd 2024

Understanding and Managing Intermediate-Risk Prostate Cancer

December 23rd 2024

2 KOLs are featured in this series.

Bridging the Gap: Key Considerations for Physicians Interpreting Gallium-Based PET Imaging

ByJaideep S. Sohi, MD,Jeremie Calais, MD

October 2nd 2024

2 KOLs are featured in this series.

Navigating Inter-readability Issues in Nuclear Medicine: Solutions for Limited Specialist Availability

ByJaideep S. Sohi, MD,Jeremie Calais, MD

October 2nd 2024

2 KOLs are featured in this series.

Collaboration in Prostate Cancer Care: The Role of PSMA PET Imaging in Multidisciplinary Teams

ByJaideep S. Sohi, MD,Jeremie Calais, MD

September 25th 2024

Trending on Diagnostic Imaging

Computed Tomography: 2025 Year in Review

FDA Clears MRI-Based AI Software for Assessment of Brain Metastases

Top Five Mammography Content for 2025

Could the PET Imaging Agent ITM-94 be a Game Changer for Detecting Clear Cell Renal Cell Carcinoma?

Advances in AI — December 2025